| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
15,830,000 |
| Market
Cap: |
33.88(M) |
| Last
Volume: |
86,028 |
Avg
Vol: |
76,335 |
| 52
Week Range: |
$1.69 - $11.04 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Inotiv is a contract research organization providing drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. Co.'s segments include: contract research services, which provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing; and research products, which designs, develops, manufactures and markets in vivo sampling systems and accessories, physiology monitoring tools, and liquid chromatography and electrochemistry instruments platforms.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
52,966 |
52,966 |
72,966 |
| Total Buy Value |
$0 |
$163,981 |
$163,981 |
$445,856 |
| Total People Bought |
0 |
2 |
2 |
3 |
| Total Buy Transactions |
0 |
2 |
2 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
5,123 |
| Total Sell Value |
$0 |
$0 |
$0 |
$58,709 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
4 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Neff R Matthew |
Director |
– • – |
2020-03-13 |
4/A |
B |
$3.93 |
$13,166 |
D/D |
3,350 |
43,430 |
2.39 |
- |
|
| Neff R Matthew |
Director |
– • – |
2020-03-13 |
4 |
B |
$3.93 |
$13,166 |
D/D |
3,350 |
45,350 |
2.39 |
30% |
|
| Neff R Matthew |
Director |
– • – |
2020-03-12 |
4/A |
B |
$3.80 |
$32,289 |
D/D |
8,497 |
40,080 |
2.39 |
- |
|
| Neff R Matthew |
Director |
– • – |
2020-03-12 |
4 |
B |
$3.80 |
$45,600 |
D/D |
12,000 |
42,000 |
2.39 |
27% |
|
| Neff R Matthew |
Director |
– • – |
2020-02-20 |
4/A |
B |
$4.60 |
$43,507 |
D/D |
9,458 |
31,583 |
2.39 |
- |
|
| Neff R Matthew |
Director |
– • – |
2020-02-20 |
4 |
B |
$4.60 |
$43,507 |
D/D |
9,458 |
30,000 |
2.39 |
-12% |
|
| Johnson Richard Allen |
Director |
– • – |
2020-02-20 |
4 |
B |
$4.63 |
$92,600 |
D/D |
20,000 |
30,000 |
2.39 |
-12% |
|
| Leasure Robert Jr. |
President and CEO |
• • – |
2020-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
177,965 |
|
- |
|
| Baim Michael |
VP Bioanalytical Services |
• – – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,718 |
22,718 |
|
- |
|
| Oakley Daniel Thomas |
Chief Operating Officer |
• – – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,974 |
57,520 |
|
- |
|
| Flynn Joseph Earl |
Chief Commercial Officer |
• – – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,564 |
127,514 |
|
- |
|
| Downing Philip A |
Sr. VP, Preclinical Srvcs. |
• – – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,436 |
34,201 |
|
- |
|
| Sagartz John E |
Director |
– • • |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,974 |
630,499 |
|
- |
|
| Blumhoff Jill |
VP, Finance & CFO |
• – – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
8,811 |
|
- |
|
| Oakley Daniel Thomas |
Chief Operating Officer |
• – – |
2019-09-13 |
4 |
B |
$3.65 |
$3,650 |
D/D |
1,000 |
48,546 |
2.66 |
- |
|
| Leasure Robert Jr. |
President and CEO |
• • – |
2019-09-13 |
4 |
B |
$3.72 |
$99,867 |
D/D |
26,846 |
164,965 |
2.81 |
- |
|
| Pitchford William D |
Chief HR Officer |
• – – |
2019-09-13 |
4 |
B |
$3.70 |
$44,400 |
D/D |
12,000 |
22,000 |
2.74 |
- |
|
| Perrow Wendy |
Director |
– • – |
2019-09-10 |
4 |
B |
$3.62 |
$36,200 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Oakley Daniel Thomas |
Chief Operating Officer |
• – – |
2019-09-06 |
4 |
B |
$3.35 |
$6,700 |
D/D |
2,000 |
47,546 |
2.74 |
- |
|
| Oakley Daniel Thomas |
Chief Operating Officer |
• – – |
2019-09-05 |
4 |
B |
$3.45 |
$36,225 |
D/D |
10,500 |
45,546 |
2.74 |
- |
|
| Leasure Robert Jr. |
President and CEO |
• • – |
2019-09-04 |
4 |
B |
$3.15 |
$36,225 |
D/D |
11,500 |
138,119 |
2.81 |
- |
|
| Oakley Daniel Thomas |
Chief Operating Officer |
• – – |
2019-08-29 |
4 |
B |
$2.69 |
$13,450 |
D/D |
5,000 |
36,046 |
2.74 |
- |
|
| Pitchford William D |
Chief HR Officer |
• – – |
2019-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Oakley Daniel Thomas |
Chief Operating Officer |
• – – |
2019-08-23 |
4 |
B |
$2.77 |
$7,185 |
D/D |
2,594 |
31,046 |
2.74 |
- |
|
| Leasure Robert Jr. |
President and CEO |
• • – |
2019-08-19 |
4 |
B |
$2.19 |
$35,040 |
D/D |
16,000 |
126,619 |
2.81 |
- |
|
177 Records found
|
|
Page 5 of 8 |
|
|
0.10 (4.46%) 
